Search

everythinglearnresearchcommunity

for

Search:↓

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Spironolactone did not make hair thinner in women with excess hair growth.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Finasteride exposure harms tadpole reproduction and hormone balance.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Lower ghrelin levels and certain gene variations may increase acne risk.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.